First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - AKARI THERAPEUTICS, PLC

ANALYSIS
Credit Risk Update: AKARI THERAPEUTICS, PLC, 42-50 Hersham Road, Walton-On-Thames, Surrey, KT12 1RZ. The legal status is a Public Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 7 October 2004.

The accounts next due date is 30 June 2024. There are 2 mortgages, 2 satisfied, none part satisfied and none unsatisfied.

The above was based on public record information as at 10 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05252842
Date Incorporated: 7 October 2004
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Public Limited Company
Previous Names: CELSUS THERAPEUTICS PLC, MORRIA BIOPHARMACEUTICALS PLC, FRESHNAME NO.333 LIMITED
Registered Number: 05252842
Annual Return: 7 October 2015
Registered Office: 42-50 Hersham Road, Walton-On-Thames, Surrey, KT12 1RZ
SIC Code and Operations: 82990
SECURED CREDITORS
Number of Mortgages 2
Satisfied Mortgages 2
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

AKARI THERAPEUTICS, PLC

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC634670 AKARI TRADING LIMITED Active
14158414 AKARI TRADING LIMITED Active
03554429 AKARI WHITCHURCH LIMITED Active
OE005291 AKARIA INVESTMENTS LIMITED Active
08975055 AKARIAN LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd